141 related articles for article (PubMed ID: 32360064)
1. Epidemiology of HPB malignancy in the elderly.
Pericleous M; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.
Coupland VH; Kocher HM; Berry DP; Allum W; Linklater KM; Konfortion J; Møller H; Davies EA
Cancer Epidemiol; 2012 Aug; 36(4):e207-14. PubMed ID: 22534487
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy.
Lewis AR; Cipriano C; Wang X; Ward R; Fitzpatrick A; Scott ARM; Rashed A; Raja H; Lamarca A; Hubner RA; Valle JW; McNamara MG
Med Oncol; 2019 Sep; 36(10):85. PubMed ID: 31493088
[TBL] [Abstract][Full Text] [Related]
4. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients?
Petrowsky H; Clavien PA
World J Surg; 2005 Sep; 29(9):1093-100. PubMed ID: 16086216
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal cancer in the elderly.
Wallach CB; Kurtz RC
Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
[TBL] [Abstract][Full Text] [Related]
6. The challenge of treating older patients with pancreaticobiliary malignancies.
Corrigan LR; Bracken-Clarke DM; Horgan AM
Curr Probl Cancer; 2018; 42(1):59-72. PubMed ID: 29459178
[TBL] [Abstract][Full Text] [Related]
7. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
8. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.
Elshami M; Ahmed FA; Hue JJ; Kakish H; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2023 Feb; 173(2):289-298. PubMed ID: 36402613
[TBL] [Abstract][Full Text] [Related]
9. Biliary Tract and Primary Liver Tumors: Who, What, and Why?
Hemming AW
Surg Oncol Clin N Am; 2019 Oct; 28(4):519-538. PubMed ID: 31472904
[TBL] [Abstract][Full Text] [Related]
10. The Demographic and Clinicopathological Characteristics of Hepatopancreatobiliary Cancers From a Specialized Center in India.
Sahai P; Yadav HP; Rastogi A
Cureus; 2023 Aug; 15(8):e43026. PubMed ID: 37674951
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
Fung BM; Lindor KD; Tabibian JH
World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
[TBL] [Abstract][Full Text] [Related]
12. Primary malignancies of the hepato-biliary-pancreatic system in organ allograft recipients.
Penn I
J Hepatobiliary Pancreat Surg; 1998; 5(2):157-64. PubMed ID: 9745082
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal malignancies in infancy, childhood, and adolescence.
Goldthorn JF; Canizaro PC
Surg Clin North Am; 1986 Aug; 66(4):845-61. PubMed ID: 3738705
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of pre-malignant disease of the pancreatico-biliary system.
Friess H; Holzinger F; Liao Q; Büchler MW
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):285-300. PubMed ID: 11355916
[TBL] [Abstract][Full Text] [Related]
15. HPB cancers in older patients | inclusion of older/senior patients in clinical trials.
Backen A; Lamarca A; Hubner RA; McNamara MG; Valle JW
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):597-602. PubMed ID: 33298342
[TBL] [Abstract][Full Text] [Related]
16. Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly.
di Sebastiano P; Festa L; Büchler MW; di Mola FF
Best Pract Res Clin Gastroenterol; 2009; 23(6):919-23. PubMed ID: 19942168
[TBL] [Abstract][Full Text] [Related]
17. Frailty assessment tools and geriatric assessment in older patients with hepatobiliary and pancreatic malignancies.
Rostoft S; van Leeuwen B
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):514-518. PubMed ID: 32933803
[TBL] [Abstract][Full Text] [Related]
18. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.
Maharaj AD; Holland JF; Scarborough RO; Evans SM; Ioannou LJ; Brown W; Croagh DG; Pilgrim CHC; Kench JG; Lipton LR; Leong T; McNeil JJ; Nikfarjam M; Aly A; Burton PR; Cashin PA; Chu J; Duong CP; Evans P; Goldstein D; Haydon A; Hii MW; Knowles BPF; Merrett ND; Michael M; Neale RE; Philip J; Porter IWT; Smith M; Spillane J; Tagkalidis PP; Zalcberg JR
BMJ Open; 2019 Sep; 9(9):e031434. PubMed ID: 31575580
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of pancreatic, gallbladder, and other biliary tract cancers.
Michaud DS
Gastrointest Endosc; 2002 Dec; 56(6 Suppl):S195-200. PubMed ID: 12447267
[No Abstract] [Full Text] [Related]
20. Epidemiology and risk factors of biliary tract and primary liver tumors.
Augustine MM; Fong Y
Surg Oncol Clin N Am; 2014 Apr; 23(2):171-88. PubMed ID: 24560105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
